# Pharmacokinetic Study of E7080/Lenvatinib in Chinese Subjects With Solid Tumor

> **NCT03009292** · PHASE1 · COMPLETED · sponsor: **Eisai Co., Ltd.** · enrollment: 12 (actual)

## Conditions studied

- Solid Tumor

## Interventions

- **DRUG:** lenvatinib

## Key facts

- **NCT ID:** NCT03009292
- **Lead sponsor:** Eisai Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-08-06
- **Primary completion:** 2018-12-24
- **Final completion:** 2021-08-27
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2021-09-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03009292

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03009292, "Pharmacokinetic Study of E7080/Lenvatinib in Chinese Subjects With Solid Tumor". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT03009292. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*